The 'Week in Review' - 21 April

This is a preview of subscriber content

Subscribe now to continue reading.

Culture and capability have been the focus this week. Will new leadership lead to change? Pre-Budget announcements are now coming 'thick and fast' but what else might we expect? We respond to questions from the audience about 'secrecy' and why the absence of celebrations about the 75th anniversary of the creation of the PBS? …

Subscribe now to continue reading.

The 'Week in Review' - 21 April

This is a preview of subscriber content

Latest Video

Most Read

New report highlights widening gap in access to modern medicines between Australia and NZ

AstraZeneca becomes the latest to say it could halt UK investment over 'appalling' pricing regime

Pharmaceutical spending to rise by around $10 billion, but still lose ground to other programs

CUREator opens $33 million funding round with CSL and AbbVie partnership

AusBiotech’s annual report highlights a defining year for Australia’s life sciences sector

New Stories

This exchange on the HTA Review was about as underwhelming as it sounds

AusBiotech unveils international conference program for Australia’s biggest week in biotech

Life sciences industry calls for stronger national strategy to support trials and innovation

Officials outline ongoing measures to address ADHD medicine shortages

Pharmaceutical spending to rise by around $10 billion, but still lose ground to other programs

Australian company reports positive outcome from collaboration

CUREator opens $33 million funding round with CSL and AbbVie partnership

Sign In

The 'Week in Review' - 21 April

This is a preview of subscriber content

Latest Video

Most Read

New report highlights widening gap in access to modern medicines between Australia and NZ

AstraZeneca becomes the latest to say it could halt UK investment over 'appalling' pricing regime

Pharmaceutical spending to rise by around $10 billion, but still lose ground to other programs

CUREator opens $33 million funding round with CSL and AbbVie partnership

AusBiotech’s annual report highlights a defining year for Australia’s life sciences sector

Follow Us

New Stories

This exchange on the HTA Review was about as underwhelming as it sounds

AusBiotech unveils international conference program for Australia’s biggest week in biotech

Life sciences industry calls for stronger national strategy to support trials and innovation

Officials outline ongoing measures to address ADHD medicine shortages

Pharmaceutical spending to rise by around $10 billion, but still lose ground to other programs

Australian company reports positive outcome from collaboration

CUREator opens $33 million funding round with CSL and AbbVie partnership